vendredi 4 août 2017

Onco Actu du 4 août 2017

Pour info : Onco Actu interrompt sa parution quotidienne, elle reprendra le 28 août.

1. Biologie

Discovery points to drugs that would ‘short-circuit’ deadly leukemia [St. Jude Children's Research Hospital]

Study reveals genetic diversity of cancer that has spread [Cancer Research UK]

Immune Contexture of Cancer [ESMO]

3.1 Tabac

Why anecdotes aren’t strong evidence when it comes to quitting smoking [The Conversation]

FDA Announces New Comprehensive Plan for Tobacco and Nicotine Regulation [ASCO]

4. Dépistage, diagnostic et pronostic

NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome [NCI]

5. Traitements

Existing arthritis drug could save thousands in blood cancer treatment [Pharmafile]

Ferreting Out Causes of Resistance to Cancer Drugs [Penn Medicine]

5.10 Traitements - Essais

A surprising amount of medical research isn’t made public. That's dangerous. [Vox]

5.2.2 Pharma - Fusions & Acquisitions

IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout [Xconomy]

Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology Pipeline Focus on Innate Immunity [BMS]

Bristol-Myers Squibb in $2.3B I-O biotech biobucks buyout deal [FierceBiotech]

Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal [EndPoints]

Bristol-Myers to buy IFM Therapeutics to strengthen cancer pipeline [Reuters]

5.3.4 Traitements - AMM (FDA, EMA)

FDA offers another speedy cancer drug OK, approving Jazz’s Vyxeos for acute myeloid leukemia [EndPoints]

FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia [FDA]

5.4 Traitements - Economie

Pancreatic cancer patients to have routine access to life extending drug after new deal, says NICE [NICE]

Pancreatic cancer patients in England get CDF access to Abraxane [Pharma Times]

NICE leans towards a ‘no’ for Keytruda in urothelial cancer [Pharma Times]

6. Lutte contre les cancers

Glioblastoma—Unraveling the Threads: A Q&A with Drs. Mark Gilbert and Terri Armstrong of the NIH Neuro-Oncology Branch [NCI]

6.10 Politiques

CAREFOR Calls on EU to Safeguard Independent Academic Research [ESMO]

6.10.1 Politiques (USA)

Senate approves key FDA legislation, sending bill to Trump’s desk [STAT]

Libertarians score big victory in 'right-to-try' drug bill [Politico]

Senate Passes F.D.A. Funding and ‘Right to Try’ Drug Bills [NY Times]

6.11 Patients

Here’s What Not to Say to Someone With Cancer [NY Mag]

6.6 Publications

What Does Transparent Peer Review Mean and Why is it Important? [The Scholarly Kitchen]

6.9 Controverses

Gene editing used to repair diseased genes in embryos [NHS Choices]